Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 79Squamous Cell Carcinoma of Head and Neck 44Lung Neoplasms 35Urinary Bladder Neoplasms 22Oropharyngeal Neoplasms 22Nasopharyngeal Carcinoma 18Head and Neck Neoplasms 18Parkinson Disease 4, Autosomal Dominant Lewy Body 15Carcinoma 15Biliary Tract Neoplasms 15Small Cell Lung Carcinoma 14Esophageal Squamous Cell Carcinoma 14Uterine Cervical Neoplasms 13Neoplasm Metastasis 13Cholangiocarcinoma 13Neoplasms 12Colorectal Neoplasms 12Pancreatic Neoplasms 11Ovarian Neoplasms 11Carcinoma, Squamous Cell 11Laryngeal Neoplasms 10Stomach Neoplasms 9Mouth Neoplasms 9Endometrial Neoplasms 9Gallbladder Neoplasms 8Carcinoma, Transitional Cell 8Hypopharyngeal Neoplasms 7Esophageal Neoplasms 7Triple Negative Breast Neoplasms 6Mesothelioma, Malignant 6

Interventions

pembrolizumab 1Fluorouracil 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Malignant Solid Tumor × Cisplatin × 90 days × Clear all
NCT06057038 2026-06-02

A Safety Trial of GEN1042 in Japanese Subjects With Malignant Solid Tumors

Genmab

Phase 1 Active not recruiting
42 enrolled
Other solid neoplasm

Malignant Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡